BioNTech SE - ADR (BNTX) Company Profile & Statistics

BioNTech SE - ADR
BNTX
(Nasdaq - US)
Closed
108.70
+6.67 (+6.54%)
in:usd•As of: Sep 29, 2023 15:59 UTC -4
After Market:108.64-0.06 (-0.06%)
Open
102.89
High
110.35
Low
102.89

About BioNTech SE - ADR

CEO

Ugur Sahin

Headquarters

an der goldgrube 12

mainz, 2m 55131, germany

Auditor

Ernst & Young GmbH

Employees

4,530

Share Holders

N/A

Website

www.biontech.de

Industry

biotechnology

Sector

health technology

Company Overview

BioNTech SE is a biotechnology company. It develops and commercializes immunotherapies for cancer and other diseases. BioNTech SE is based in Mainz, Germany.

BioNTech SE - ADR Statistics

Valuation Measures

Market Capitalization ²	26.20B
Enterprise Value	10.97B
Enterprise Value/EBITDA (ttm)	1.87
Price to Earnings Ratio (ttm)	6.09
Price to Book (mrq)	1.21
Price to Sales (ttm)	2.78
Price to Cash (ytd)	2.62

Profitability

Gross Margin (ttm)	67.62%
Operating Margin (ttm)	47.37%
Profit Margin (ttm)	7.52%
Return on Equity (ttm)	21.46%
Return on Invested Capital (ttm)	21.48%
Return on Assets (ttm)	18.71%

Income Statement

Revenue (ttm)	9.24B
Revenue Per Share (ttm)	N/A
Gross Profit (ttm)	8.07B
EBITDA (ttm)³	5.86B
Net Income Avi to Common (ttm)	4.34B
Diluted EPS (ttm)	17.84

Share Statistics

Beta (5Y Monthly)	0.17
52-Week Change	-20.47%
S&P500 52-Week Change	16.57%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	N/A
Dividend Yield	0.00%
Float ⁴	194.72M
% Held by Insiders	19.20%
% Held by Institutions	15.52%

Balance Sheet

Total Cash (mrq)	16.96B
Total Cash Per Share (mrq)	N/A
Total Debt (mrq)	224.30M
Total Debt/Equity (mrq)	1.03%
Current Ratio (mrq)	10.56%
Quick Ratio (mrq)	10.32%
Book Value Per Share (mrq)	90.53

Cash Flow

Operating Cash Flow Per Share (ytd)	16.78
Free Cash Flow (ytd)	3.92B

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

BioNTech SE - ADR

Trade With A Regulated Broker